All In Biotech

Free tool

FAERS Monitor: Hemangeol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205410 or its brand name (Hemangeol, Propranolol Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

15,795

Serious

8,000

51% of reports

Hospitalization

3,304

Death reported

1,476

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use3,538
  • drug ineffective1,369
  • product use issue1,177
  • product use in unapproved indication987
  • nausea930
  • inappropriate schedule of product administration914
  • diarrhoea851
  • product administered to patient of inappropriate age832
  • headache799
  • fatigue796
  • toxicity to various agents695
  • vomiting635
  • drug intolerance616
  • dyspnoea578
  • condition aggravated562

Reports by year received

View as table
YearReports
200499
2005162
2006127
200798
200879
2009153
2010174
2011164
2012203
2013141
2014146
2015164
2016296
2017299
2018524
2019639
20201,084
2021897
20221,990
20232,089
20242,693
20252,017
20261,557

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,364 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product administered to patient of inappropriate ageSignal832210.8196.3149,852
drug intoleranceSignal6168.57.94,085
product use issueSignal1,1778.47.97,670
inappropriate schedule of product administrationSignal9146.86.44,516
toxicity to various agentsSignal6955.55.12,569
off label useSignal3,5385.45.213,171
product use in unapproved indicationSignal9875.35.03,486
condition aggravatedSignal5622.52.3494
vomiting6351.81.7230
diarrhoea8511.81.6285
headache7991.71.6235
nausea9301.61.5197
drug ineffective1,3691.41.3155
fatigue7961.41.379
dyspnoea5781.41.356

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.